Jonathan M. Edelman

7.4k citations

90 papers · 4.6k indexed · 2 hit papers · h-index 31

Impact in

Cardiology and Cardiovascular Medicine top 0.5%
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
- Renin-Angiotensin System Studies
- Heart Rate Variability and Autonomic Control
- Heart Failure Treatment and Management
Endocrinology, Diabetes and Metabolism top 1%
- Hormonal Regulation and Hypertension

Papers in

Cardiology and Cardiovascular Medicine 31
- Blood Pressure and Hypertension Studies 20
- Cardiovascular Function and Risk Factors 10
- Cardiac electrophysiology and arrhythmias 8
Genetics 12
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 10

Co-authors: Markku S. Nieminen Sverre E. Kjeldsen Stevo Julius Richard B. Devereux Lars Lindholm Steven Snapinn Björn Dahlöf Hans Ibsen
Journals: Journal of Allergy and Clinical Immunology (8 papers)Annals of Allergy Asthma & Immunology (5 papers)Circulation (5 papers)European Respiratory Journal (3 papers)Clinical Therapeutics (3 papers)
Partner nations: United States Sweden Denmark

In The Last Decade

Jonathan M. Edelman

84 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial 2015 · 325 citations

Peers

Countries citing papers authored by Jonathan M. Edelman

Since Specialization

Citations

This map shows the geographic impact of Jonathan M. Edelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan M. Edelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan M. Edelman more than expected).

Fields of papers citing papers by Jonathan M. Edelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan M. Edelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan M. Edelman. The network helps show where Jonathan M. Edelman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jonathan M. Edelman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan M. Edelman Line = papers co-authored together Jonathan M. Edelman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Life Expectancy and Determinants of Relative Survival Following Surgical Aortic Valve Replacement for Aortic Stenosis Heart Lung and Circulation ·Scotty Butcher, Ágnes Harmath, Charley Budgeon, J.T.S. Walker, Riya Johns, G. R. Graham, Frank Sanfilippo, Lance A. Waller, S. M. Huggins, Dmitriy Yamkovoy, Timothy Gilbert, Jürgen Passage, Jonathan M. Edelman, Jamie Rankin, T. Briffa, Luis F.A. Toledo	2025	0
2	Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert® (C1-INH) Registry Drugs & Aging ·Anette Bygum, Inmaculada Martinez‐Saguer, Murat Baş, Elena Onischenko, Jonathan M. Edelman, Mikhail Rojavin, Debora Williams‐Herman, (unknown)	2016	8
3	Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitor Annals of Allergy Asthma & Immunology ·Henriette Farkas, Lilian Varga, Dumitru Moldovan, Krystyna Obtułowicz, Sofie Demasure, Thomas Machnig, Henrike Feuersenger, Jonathan M. Edelman, Debora Williams‐Herman, Mikhail Rojavin	2016	6
4	Lung Deposition of Alpha ₁ -Proteinase Inhibitor (Human) (A ₁ -PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Sabine Häußermann, Andrew K. Jarvis, Jonathan M. Edelman, Dominik Kappeler, C Herpich, Liisa Heinonen, José Fernando Barandas, H. J. Maletta, Knut Sommerer	2015	7
5	Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial The Lancet ·Kenneth R. Chapman, Jonathan Burdon, Eeva Piitulainen, Robert A. Sandhaus, Niels Seersholm, James Stocks, Berend C. Stoel, Liping Huang, Zhenling Yao, Jonathan M. Edelman, Noel G. McElvaney Hit paper breakdown →	2015	325
6	Integrated safety across six clinical trials of alpha-1 augmentation therapy European Respiratory Journal ·Robert A. Sandhaus, Kenneth R. Chapman, Jonathan Burdon, Eeva Piitulainen, Niels Seersholm, James Stocks, Jonathan M. Edelman, Martin Bexon, Liping Huang, Noel G. McElvaney	2014	2
7	Baseline Patient Demographics and Lung Density Decline in the RAPID Trial CHEST Journal ·James Stocks, Robert A. Sandhaus, Kenneth R. Chapman, Jonathan Burdon, Eeva Piitulainen, Niels Seersholm, Liping Huang, Jonathan M. Edelman, Noel G. McElvaney	2014	1
8	Safety of C1-Esterase Inhibitor in Acute and Prophylactic Therapy of Hereditary Angioedema: Findings from the Ongoing International Berinert Patient Registry The Journal of Allergy and Clinical Immunology In Practice ·Paula J. Busse, Anette Bygum, Jonathan M. Edelman, William R. Lumry, Thomas Machnig, Inmaculada Martinez‐Saguer, Mikhail Rojavin	2014	23
9	Serial Assessment of the Electrocardiographic Strain Pattern for Prediction of New-Onset Heart Failure During Antihypertensive Treatment: The LIFE Study European Journal of Heart Failure ·Peter M. Okin, Lasse Oikarinen, Matti Viitasalo, Lauri Toivonen, Sverre E. Kjeldsen, Markku S. Nieminen, Jonathan M. Edelman, Björn Dahlöf, Richard B. Devereux, (unknown)	2011	13
10	Greater Regression of Electrocardiographic Left Ventricular Hypertrophy During Hydrochlorothiazide Therapy in Hypertensive Patients American Journal of Hypertension ·Peter M. Okin, Darcy A. Hille, Sverre E. Kjeldsen, Lars Lindholm, Jonathan M. Edelman, Björn Dahlöf, R DEVEREUX	2010	13
11	Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study Blood Pressure ·Sverre E. Kjeldsen, Richard B. Devereux, Darcy A. Hille, Paulette A. Lyle, Björn Dahlöf, Stevo Julius, Jonathan M. Edelman, Steven Snapinn, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, (unknown)	2009	15
12	Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study Journal of Hypertension ·Peter M. Okin, Richard B. Devereux, Sverre E. Kjeldsen, Jonathan M. Edelman, Björn Dahlöf	2009	13
13	Abstract 4421: Concomitant Hydrochlorothiazide Therapy in Hypertensive Patients is Associated with Reduced Cardiovascular Morbidity and Mortality Independent of Blood Pressure and Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study Circulation ·Peter M. Okin, Richard B. Devereux, Darcy A. Hille, Sverre E. Kjeldsen, Lars Lindholm, Jonathan M. Edelman, Björn Dahlöf	2008	2
14	Atenolol as a comparator in outcome trials in hypertension: A correct choice in the past, but not for the future? Blood Pressure ·Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen, Paulette A. Lyle, Zhongxin Zhang, Jonathan M. Edelman	2007	7
15	Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial Journal of Allergy and Clinical Immunology ·Cynthia S. Rand, Andrew Bilderback, Edineia Miranda Machado, Jonathan M. Edelman, Carolyn M. Hustad, Robert S. Zeiger	2007	74
16	812-4 Serum uric acid and ischemic stroke risk among hypertensive patients with left ventricular hypertrophy: The losartan intervention for endpoint reduction in hypertension (LIFE) study Journal of the American College of Cardiology ·Jorge R. Kizer, Aud Høieggen, Michael H. Alderman, Sverre E. Kjeldsen, Björn Dahlöf, Stevo Julius, Gareth Beevers, Ulf dé Fairé, F Fyhrquist, Hans Ibsen, Maristela Mulino, Ole Lederballe‐Pedersen, Lars Lindholm, Kljajević Ljiljana M., Per Omvik, Suzanne Oparil, Hans Wedel, Jonathan M. Edelman, Steven Snapinn, Richard B. Devereux	2004	4
17	Evaluation of Parental Preference for the Treatment of Asthmatic Children Aged 6 to 11 Years with Oral Montelukast or Inhaled Cromolyn: A Randomized, Open-Label, Crossover Study Journal of Asthma ·Don A. Bukstein, Donna L. Bratton, Lukas Gottschamel, Steven Gallinger, Steven Bird, Carolyn M. Hustad, Jonathan M. Edelman	2003	28
18	Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy JAMA ·Sverre E. Kjeldsen, Björn Dahlöf, Richard B. Devereux, Stevo Julius, Peter Aurup, Jonathan M. Edelman, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Krister Kristianson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Steven Snapinn, Hans Wedel, IIu Dzarma	2002	302
19	Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension Clinical Therapeutics ·Qiao-Feng Qiu, Eliav Barr, P. G. Waser, Charles Liss, 水野皓介, Jonathan M. Edelman	1996	72
20	Lipopolysaccharide stimulates alveolar macrophage adherencein vivo andin vitro Inflammation Research ·Jonathan M. Edelman, Christopher Cardozo, Marvin Lesser	1989	14

About Jonathan M. Edelman

Jonathan M. Edelman is a scholar working on Cardiology and Cardiovascular Medicine, Genetics, Immunology and Allergy, Endocrinology, Diabetes and Metabolism and Hematology, having authored 90 papers that have together received 4.6k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (20 papers), Asthma and respiratory diseases (18 papers), Respiratory and Cough-Related Research (13 papers), Hormonal Regulation and Hypertension (12 papers), Cardiovascular Function and Risk Factors (10 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers), Inhalation and Respiratory Drug Delivery (9 papers) and Cardiac electrophysiology and arrhythmias (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2.6k citations), Endocrinology, Diabetes and Metabolism (1.2k citations), Immunology and Allergy (221 citations), Physiology (840 citations) and Pulmonary and Respiratory Medicine (973 citations). Jonathan M. Edelman has collaborated with scholars based in United States, Sweden and Denmark. Frequent co-authors include Markku S. Nieminen, Sverre E. Kjeldsen, Stevo Julius, Richard B. Devereux, Lars Lindholm, Steven Snapinn, Björn Dahlöf, Hans Ibsen, Peter Aurup and Gareth Beevers. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Annals of Allergy Asthma & Immunology, Circulation, European Respiratory Journal and Clinical Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact